GleamWall
中文EN

PYXS Pyxis Oncology, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1782223 · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (2024Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-4.8%
TTM EPS YoY28.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin97.1%
Operating margin-554.1%
Net margin-478.9%
FCF margin-358.7%
EBITDA margin-535.6%

Returns

ROE-62.8%
ROA-46.7%
ROIC (approx.)-65.0%
Asset turnover0.10x

Leverage & solvency

Liabilities / assets23.2%
Debt / equity0.00x
Current ratio7.49x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.75x
Accruals ratio-11.9%
Payout ratio—
Capex / revenue1.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$13.86M$16.15M
Cost of revenue$2.39M$475,000
Gross profit$11.47M$15.67M
R&D expense$73.70M$58.75M
SG&A expense$22.19M$25.42M
Operating income-$84.42M-$89.46M
Pretax income-$78.23M-$79.50M
Income tax$1.39M-$2.16M
Net income-$79.62M-$77.33M
EBITDA-$79.91M-$86.48M
EPS (basic)-1.28-1.32
EPS (diluted)-1.28-1.32
Weighted avg. shares (diluted)62.14M58.45M
Balance sheet
Cash & equivalents$15.42M$19.47M
Short-term investments$51.44M$107.46M
Current assets$72.11M$132.44M
PP&E, net$8.00M$9.90M
Intangibles$0$2.60M
Total assets$91.52M$157.18M
Current liabilities$21.13M$17.68M
Total liabilities$38.11M$36.43M
Shareholders' equity$53.41M$120.75M
Shares outstanding62.69M59.97M
Cash flow statement
Operating cash flow-$63.50M-$57.67M
Capital expenditure$9,000$237,000
Free cash flow-$63.51M-$57.91M
Investing cash flow$58.86M$8.15M
Financing cash flow$594,000$59.33M
Depreciation & amortization$4.51M$2.98M
Stock-based compensation$11.80M$12.95M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.